Home » Topics » BioWorld Science

BioWorld Science
RSS

Promising preliminary phase II results for argatroban in acute MI

Oct. 25, 1996

Anti-TNF MAb effective in treating septic shock in two major studies

Oct. 25, 1996

Progress on Neuprex for hemorrhagic trauma

Oct. 25, 1996

cGMP PDE inhibitors reported by DuPont Merck

Oct. 25, 1996

AM-140 available for licensing

Oct. 25, 1996

Antiarrhythmic compounds described by SKB

Oct. 25, 1996

PLC Systems' Heart Laser superior to holmium and excimer lasers for TMR

Oct. 25, 1996

GV-1201/GV-1202 available for licensing

Oct. 25, 1996

Gensia turns over development of Geomatrix nifedipine product

Oct. 25, 1996

Phase IV study results reported for ramipril

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...